Yuki Kageyama to Genetic Therapy
This is a "connection" page, showing publications Yuki Kageyama has written about Genetic Therapy.
Connection Strength
0.087
-
Development of a novel interferon-a2b gene construct with a repetitive hypoxia-inducible factor binding site and its suppressive effects on human renal cell carcinoma cell lines in vitro. Int J Clin Oncol. 2014; 19(3):497-504.
Score: 0.078
-
Adenoviral vectors containing the CTLA4IG-gene inhibit chronic rejection in heterotopically transplanted rat tracheas. Transplant Proc. 2000 Nov; 32(7):2036-7.
Score: 0.008